uncontrolled glaucoma. Glaucoma secondary to other eye disorders, unspecified eye, severe stage
Conditions
Interventions
Intervention 1: To insert the Ahmed Glaucoma Valve (AGV),peritomy will performed by conjunctival incision at 4 mm from the limbus in the superotemporal quadrant. Ahmed valve will prime with balance
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Uncontrolled glaucoma with full medications First shunt candidate patients
Exclusion criteria
Exclusion criteria: Under 18 years old patients Secondary neovascular glaucoma due to tumor or uveitis Under 6 month follow up Previous shunts pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IOP changes after Ahmed valve implantation with sub-conjunctival injection of bevacizumab or mitomycin. Timepoint: IOP measurement before surgery, 1, 7, 30 days and 3, at least 6 month after surgery and in the last follow up after surgery. Method of measurement: Goldman tonometer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of glaucoma medication after surgery. Timepoint: Baseline,first day,one week,first month,three months,6 months and last follow up. Method of measurement: counting the number of antiglaucoma drugs.;Complications in each group. Timepoint: first day,First week,first month,three months,6months after surgery. Method of measurement: qualitative and descriptive. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Arezoo Miraftabi
Iran University of Medical Sciences
Outcome results
None listed